Loading...

CHAIN BRIDGE I Disposals and divestitures 8-K Filing

CHN

CHAIN BRIDGE I

()

2025 8-K

Delisting Notice

Shareholder Meeting Outcome

Promissory Note Issued

Funding Agreement

Business Combination Announced

Changes in accounting firms

Agreement Termination

Financial Restatement

Delisting Notice

Delisting Notice

Non-Redemption Agreement

Meeting Postponement

Expense Reimbursement

Nasdaq Compliance

Business Combination Agreement

Merger of Equals

Management Change

Appointment of Director

Amendments to Articles of I...

Amendment to Disclosure

Extension of Business Opera...

Acquisition and Management ...

Resignations and Acquisitio...

Redemption of Shares

Departure of Directors or C...

Meeting Approval for Extens...

Non-Redemption Agreements

Shareholder Meeting for Pot...

External Links:

Chain Bridge I and Phytanix Bio mutually terminated their Business Combination Agreement on April 7, 2025, and the company changed its accounting firm from Frank, Rimerman & Co. LLP to RBSM, LLP on April 4, 2025, due to prior financial statement errors requiring restatement.

AI Assistant

CHAIN BRIDGE I

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.